Post by Dealert

6.0-8.0x EV/EBITDA for a German homecare distributor is a quietly aggressive price. Axcel signed to acquire sangro medical service GmbH 🇩🇪 - a carve-out from GHD GesundHeits GmbH, and Axcel’s first investment in Germany. Dealert estimates EV of $97m-$132m on $14m-$18m EBITDA (and $170m-$230m revenue, ~0.5-0.6x EV/Revenue). Take: this looks like a bet that independence unlocks growth faster than the “carve-out discount” would suggest - especially in homecare distribution where scale and service density matter. If 6-8x is the clearing multiple here, what does that imply for the next German homecare platform? 🔗 Full details: https://lnkd.in/exZWnUgj #MergersAndAcquisitions #PrivateEquity #GermanPrivateEquity #Strategy #Healthcare